TABLE 1.
Patient | Expanded NK Cells | Days in Culture | Feeder Cells* | CD56 TRAIL (MFI) | Viability |
---|---|---|---|---|---|
1 | eNK-1-1 | 14 | LCL-1-1-D16 | 1,741 | 90 |
| |||||
2 | eNK-2-1 | 14 | LCL-1-2-D28 | 1,008 | 86 |
eNK-2-2 | 14 | LCL-1-5-D75 | 1,779 | 86 | |
eNK-2-3 | 14 | LCL-2-2-D29 | 838 | 84 | |
eNK-2-4 | 14 | LCL-3-4-D46 | 1,104 | 81 | |
| |||||
3 | eNK-3-1 | 15 | LCL-1-2-D28 | 860 | 89 |
eNK-3-2 | 14 | LCL-1-5-D75 | 563 | 86 | |
eNK-3-3 | 15 | LCL-3-3-D43 | 354 | 89 | |
| |||||
4 | eNK-4-1 | 16 | LCL-2-1-D15 | 1,573 | 86 |
| |||||
5 | eNK-5-1 | 15 | LCL-2-1-D15 | 1,460 | 88 |
eNK-5-2 | 15 | LCL-3-2-D24 | 1,500 | 90 | |
| |||||
6 | eNK-6-1 | 16 | LCL-3-2-D24 | 921 | 91 |
| |||||
7 | eNK-7-1 | 14 | LCL-3-5-D64 | 2,330 | 85 |
| |||||
8 | eNK-8-1 | 14 | LCL-4-1-D69 | 1,394 | 71 |
LCL indicates lymphoblastoid cell line; eNK, expanded NK; D, days.
Corresponding feeder cells of which specimens were available.